Ashlee was diagnosed with high-risk neuroblastoma at the age of six but relapsed for the second time in November 2018, devastating her family. They know that her future is uncertain as once a child relapses, their chances of long-term survival drop drastically to less than one in ten.

She is now receiving immunotherapy, after which her family hope to access a vaccine in New York that aims to keep the cancer from returning.

Ashlee needs £239,000 so she can start the clinical trial in February.

Shona Penman